Clinical Trials
3 trialsNCT06432296 2026-05-11
Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 3 Active not recruiting
NCT05998135 2025-09-11
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Emory University
Phase 2 Recruiting
NCT06266091 2025-07-20
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 2 Completed